Alliance for Human Research Protection - Grassley Probe: Pharma Provides 81% of NAMI Income

"It is difficult to say, who are the most culpable in betraying the trust and best interests of people with mental illness--psychiatrists whose prescribing practice is entirely governed by commercial interests? Or, NAMI, whose mission as a family advocacy organization on behalf of people with mental illness has been betrayed when it joined forces with drug manufacturers."- Vera Hassner Sharav

via ahrp.org

Between 2005--2009, the following NAMI chapters reported their pharmaceutical intake:

NAMI-California received $632,000 from drug companies;
NAMI-Ohio received $623,000;
NAMI-New York received $448,000;
NAMI-Florida received $414,000;
NAMI-Indiana received $356,000;
NAMI-Massachusetts received $308,000;
NAMI-Minnesota received $291,000;
NAMI-Delaware received $269,000
and NAMI-Pennsylvania and NAMI-North Carolina each received $250,000.

NAMI-Alabama; NAMI-Arizona; NAMI-Connecticut and NAMI-Hawaii have yet to respond to Sen. Grassley's request.

The companies that bankrolled NAMI chapters:
Eli Lilly provided $2,200,000; AstraZeneca provided $1,600,000; BristolMyersSquibb provided $1,300,000; Janssen (Johnson & Johnson) provided $470,000 and GlaxoSmithKline provided $305,000.

Posted via web from Jack's posterous